Medication Treatment of ADHD in Pediatric Epilepsy
NCT07594652
This study is recruiting at 1 US site in 1 state, according to its ClinicalTrials.gov record last updated .
Summary
This is an observational study assessing the usage of stimulant medication for ADHD in the context of pediatric epilepsy.
Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov
Conditions studied
- ADHD - Attention Deficit Disorder With Hyperactivity
Eligibility basics and study details
- Study type
- Interventional
- Phase
- Phase 4
- Ages
- 6 to 17 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Sponsor
- Hugo W. Moser Research Institute at Kennedy Krieger, Inc.
- Last updated on ClinicalTrials.gov
- July 29, 2026
These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.
US recruiting sites
Maryland · 1
- Kennedy Krieger Institute · Baltimore, MD
Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.